Tazobactam Sodium
C10H11N4NaO5S
322.27
4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3-methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-, 4,4-dioxide, sodium salt, [2S-(2α,3β,5α)]-;
Sodium (2S,3S,5R)-3-methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate 4,4-dioxide [89785-84-2]
4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3-methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-, 4,4-dioxide, sodium salt, [2S-(2α,3β,5α)]-;
Sodium (2S,3S,5R)-3-methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate 4,4-dioxide [89785-84-2]
DEFINITION
Tazobactam Sodium contains NLT 98.0% and NMT 102.0% of tazobactam sodium (C10H11N4NaO5S), calculated on the anhydrous basis.
USP REFERENCE STANDARDS FOR PURCHASE
USP Tazobactam RSUSP Tazobactam Related Compound A RS
USP Tazobactam Sodium RS